Abstract:Pharmaceuticals are recognised among emerging contaminants, particularly in water. They have the potential to alter ecosystem dynamics, with notable examples including hormone-induced feminization of male fish and disruptions to oogenesis in invertebrates. To assess the risk posed by pharmaceuticals, it is essential to understand their amount (via Measured Environmental Concentrations MEC) and their actual effects on target species (via Predicted No Effect Concentrations PNEC). Recently, many studies have aimed to collect MEC data from around the world, but a comprehensive overview is still lacking. Thus, the objective of this study is to provide a comprehensive overview by examining recently published literature on MEC data for a wide range of pharmaceuticals. Additionally, to enable risk assessment, this study also reviewed the published literature on PNEC data and integrated it with existing databases. A total of 315 substances were selected for MEC data extraction, with the inclusion of 56 articles. The most frequently monitored locations were Cadiz Bay in Spain (90 samples), the River Thames in the UK (51), and Hrdějovice in the Czech Republic (49). Most MEC samples were collected from surface water (N=325), influent wastewater treatment plants (WWTP) (205), and effluent WWTP (118). Based on PNEC values, risk analysis identified 81 pharmaceuticals as high-risk, with the highest risk values for propranolol (risk quotient [RQ]: 29,450,000), diclofenac (395,920), and 17alpha-ethinylestradiol (95,946). Additionally, the ATC classes with the most high-risk substances were anti-infectives (J), nervous system agents (N), cardiovascular agents (C), antineoplastic agents (L), analgesics (M), and sex hormones (G). The findings of this study highlight the widespread impact of pharmaceuticals across the globe and the involvement of multiple therapeutic classes. To move beyond the current point-in-time overview, which is limited to specific locations and sampling periods, systems for continuous monitoring of pharmaceuticals should be developed. This could involve the creation of resource-efficient methods and the integration of sampling data with estimation models. Furthermore, these results could serve as a starting point for developing and implementing actions to prevent and mitigate the environmental impact of pharmaceuticals.

Emerging challenges of the impacts of pharmaceuticals on aquatic ecosystems: A diatom perspective

The impact of pharmaceutical pollutants on daphnids - A metabolomic approach

Bioaccumulation and biomagnification potential of pharmaceuticals with a focus to the aquatic environment

Impact of emerging pollutants mixtures on marine and brackish phytoplankton: diatom Phaeodactylum tricornutum and cyanobacterium Microcystis aeruginosa

Pharmaceuticals in Water: Risks to Aquatic Life and Remediation Strategies

A review of the effects of pharmaceutical pollutants on humans and aquatic ecosystem

Pollution of Soil by Pharmaceuticals: Implications for Metazoan and Environmental Health

The environmental impact of pharmaceuticals: an evidence-mapping review of recent data on aquatic concentrations and predictable effects

Human pharmaceuticals in the marine environment: Focus on exposure and biological effects in animal species

Occurrence, fate and transformation of emerging contaminants in water: An overarching review of the field

Pharmaceutical Pollution in Aquatic Environments: A Concise Review of Environmental Impacts and Bioremediation Systems

Ecotoxicity, Occurrence, and Removal of Pharmaceuticals and Illicit Drugs from Aquatic Systems

Environmental fate of aquatic pollutants and their mitigation by phycoremediation for the clean and sustainable environment: A review

A review on microalgae-mediated biotechnology for removing pharmaceutical contaminants in aqueous environments: Occurrence, fate, and removal mechanism

Occurrence and potential risks of pharmaceutical contamination in global Estuaries: A critical review and analysis

[Pharmaceutical residues in aquatic compartments : Status quo and perspectives]

Environmental impact and source-controlled approaches for emerging micropollutants: Current status and future prospects

Photodegradation of Typical Pharmaceuticals Changes Toxicity to Algae in Estuarine Water: A Metabolomic Insight.

Microplastics and Antibiotics in Aquatic Environments: A Review of Their Interactions and Ecotoxicological Implications

Emerging contaminants in the aquatic environment: phytoplankton structure in the presence of sulfamethoxazole and diclofenac

Effects of pharmaceuticals and personal care products on marine organisms: from single-species studies to an ecosystem-based approach